---
figid: PMC6745797__12943_2019_1062_Fig2_HTML
figlink: /pmc/articles/PMC6745797/figure/Fig2/
number: F2
caption: 'Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
  and MHC in EGFR-mutant NSCLC. Activation of EGFR may lead to downregulation of MHC
  expression through the MEK/ERK signaling pathway. In addition, activation of EGFR
  may influence expression of IFN-γR, generating intracellular signals that induce
  expression of the CIITA gene. CIITA is recruited to the MHC promoter, activating
  transcription. The net result is attenuation of CIITA and MHC molecule expression.
  In response to EGFR-TKIs, expression of CIITA and MHC genes is derepressed. In addition,
  EGFR-TKIs enhance MHC expression by inhibiting ERK activation. CIITA: class II major
  histocompatibility complex transactivator; TME: tumor microenvironment; MEK/ERK:
  extracellular signal–regulated kinase (ERK) kinase MEK; IFN-γR: interferon γ receptor;
  MHC: major histocompatibility complex; EGFR-TKIs: epidermal growth factor receptor
  tyrosine kinase inhibitors; EGFR: epidermal growth factor receptor; IFN-γ: interferon-γ'
pmcid: PMC6745797
papertitle: Role of the dynamic tumor microenvironment in controversies regarding
  immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC)
  with EGFR mutations.
reftext: Anqi Lin, et al. Mol Cancer. 2019;18:139.
pmc_ranked_result_index: '30867'
pathway_score: 0.9609425
filename: 12943_2019_1062_Fig2_HTML.jpg
figtitle: Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
  and MHC in EGFR-mutant NSCLC
year: '2019'
organisms: Homo sapiens
ndex: fbd509c8-deae-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6745797__12943_2019_1062_Fig2_HTML.html
  '@type': Dataset
  description: 'Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
    and MHC in EGFR-mutant NSCLC. Activation of EGFR may lead to downregulation of
    MHC expression through the MEK/ERK signaling pathway. In addition, activation
    of EGFR may influence expression of IFN-γR, generating intracellular signals that
    induce expression of the CIITA gene. CIITA is recruited to the MHC promoter, activating
    transcription. The net result is attenuation of CIITA and MHC molecule expression.
    In response to EGFR-TKIs, expression of CIITA and MHC genes is derepressed. In
    addition, EGFR-TKIs enhance MHC expression by inhibiting ERK activation. CIITA:
    class II major histocompatibility complex transactivator; TME: tumor microenvironment;
    MEK/ERK: extracellular signal–regulated kinase (ERK) kinase MEK; IFN-γR: interferon
    γ receptor; MHC: major histocompatibility complex; EGFR-TKIs: epidermal growth
    factor receptor tyrosine kinase inhibitors; EGFR: epidermal growth factor receptor;
    IFN-γ: interferon-γ'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUN
  - CSNK2A1
  - CIITA
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - RAF1
  - BRAF
  - ARAF
  - NRAS
  - AKT3
  - AKT1
  - AKT2
  - CDC37
  - STAT5B
  - STAT6
  - STAT1
  - STAT2
  - STAT4
  - FLT1
  - CSNK2A2
  - CSNK2B
  - MAPK3
  - KRAS
  - HRAS
  - STAT3
  - STAT5A
  - BTC
  - TYK2
  - JAK3
  - JAK2
  - JAK1
  - MAP2K2
  - MAP2K1
  - MTOR
  - MYC
  - NFKB1
  - CD274
  - PIK3R3
  - PIK3CG
  - PIK3R6
  - IL6
  - EGF
  - EGFR
  - KDR
  - FLT4
  - HBEGF
  - MAPK1
  - GSK3B
  - HSP90AA1
  - EPGN
  - EREG
  - AREG
  - TGFA
  - H
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: C-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: CIITA
  symbol: CIITA
  source: hgnc_symbol
  hgnc_symbol: CIITA
  entrez: '4261'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Cdc37
  symbol: CDC37
  source: hgnc_symbol
  hgnc_symbol: CDC37
  entrez: '11140'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: V-EGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: BTC
  entrez: '685'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: V-EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: V-EGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: V-EGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Hsp90
  symbol: Hsp90
  source: hgnc_alias_symbol
  hgnc_symbol: HSP90AA1
  entrez: '3320'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EPGN
  entrez: '255324'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EREG
  entrez: '2069'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: V-EGFRligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
chemicals:
- word: H
  source: MESH
  identifier: D006859
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6745797__F2
redirect_from: /figures/PMC6745797__F2
figtype: Figure
---
